Press releases
- IQVIA to Announce First-Quarter 2021 Results on April 22, 2021
- IQVIA Acquires Remaining Interest in Q² Solutions from Quest Diagnostics; Raises Full Year 2021 Adjusted Diluted EPS Guidance
- IQVIA Virtual Trial Solutions Used in More than 60 Trials
- IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials
- IQVIA to Participate in the Barclays Global Healthcare Conference on March 09, 2021
- IQVIA Announces Pricing of Offering of Senior Notes
- AIS Announces Patricia Obermaier Microsoft VP of U.S. Health and Life Sciences Joins Board of Directors
- IQVIA Announces Offering of Senior Notes
- IQVIA’s Orchestrated Customer Engagement (OCE) Solution Selected by 140 Life Sciences Companies in Nearly 90 Countries
- IQVIA Reports Fourth-Quarter and Full-Year 2020 Results Raises Full-Year 2021 Guidance
More ▼
Key statistics
Markit short selling activity
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 191.77m |
Free float | 189.20m |
P/E (TTM) | 145.62 |
Market cap | 39.82bn USD |
EPS (TTM) | 1.43 USD |
More ▼